Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive malignancy, characterized by largely unsatisfactory responses to the currently available therapeutic strategies. In this study we evaluated the expression of genes involved in gemcitabine uptake in a selected cohort of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavano, Francesca, Fontana, Andrea, Pellegrini, Fabio, Burbaci, Francesca Paola, Rappa, Francesca, Cappello, Francesco, Copetti, Massimiliano, Maiello, Evaristo, Lombardi, Lucia, Graziano, Paolo, Vinciguerra, Manlio, di Mola, Fabio Francesco, di Sebastiano, Pierluigi, Andriulli, Angelo, Pazienza, Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172900/
https://www.ncbi.nlm.nih.gov/pubmed/25199538
http://dx.doi.org/10.1186/s12967-014-0248-4

Ejemplares similares

Ejemplares similares